2019 was an exciting year for the drug discovery field, marked by the first in vivo CRISPR and PROTAC candidates entering the clinic. As we welcome 2020, here are 10 drug discovery conferences to watch out for to catch up on the advances in this field.
January 20-24, San Diego, USA
PepTalk is one of the largest protein science gatherings in the world. Each year it attracts researchers from all around the globe for one week of intensive learning and networking. The program covers a wide spectrum, from upstream protein R&D engineering to downstream process technologies. Scheduled events include 20 topic-focused conferences, short courses, training seminars, and interactive roundtables. Save the date and meet us at booth #309.
2. SLAS 2020
January 25-29, San Diego, USA
This conference promotes scientific research and innovation by leveraging the power of laboratory technology. This year’s sessions include topics such as CRISPR-tailored cellular assays, patient-specific disease models and “off-the shelf” CAR-T therapies. The conference will also include a short courses that cover topics like 3D printing, biophysical methods in small molecule drug discovery, and many others. Come and meet us at booth #318.
March 2-4, San Diego, USA
During the Festival of Biologics, global speakers from big pharma, academia and industry will address the strategic and commercial aspects of discovering, developing and bringing new biologics to patients. This conference will feature three conferences covering antibodies, immunotherapy, biosimilars and an exhibition featuring solutions for pharma and biotech.
March 2-4, San Francisco, USA
Machine learning, specifically for drug discovery and development, is highly data-intensive with disparate types of data being generated that have historically been trial-and-error processes. Deep learning, machine learning (ML), and artificial intelligence (AI), coupled with correct data, have the potential to make these processes less error-prone and increase the likelihood of success from drug discovery to the real-world setting. This conference will discuss lessons learned from case studies as well as challenges that lay ahead.
March 8-9, London, UK
This Cambridge Healthtech Institute conference will bring together chemists, biologists, and pharmacologists to discuss the prospects as well as the challenges underlying the various strategies for targeted protein degradation. The discussion will also include the new molecular degraders, linkers, and ligases being developed as well as the assays and tools that are being used to further expand their potential.
April 13-17, San Diego, USA
Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech and is focused on discovery and optimization challenges of small molecule drug candidates. The 2020 event includes new coverage of RNA as a small molecule target, expanded coverage of artificial intelligence for early drug discovery, and several short courses to choose from. Meet us there.
June 15-17, Boston, USA
The 8th edition of this conference intends again to bring together biophysicists and medicinal chemists, the synergy between their disciplines is key to delivering better drugs in a shorter time. This year’s scientific sessions include advances in cryo-EM, selective protein degraders, covalent modifications for drug discovery, integrative structural biology & biophysics, and advances in biophysical techniques.
September 15-18, Boston, USA
Discovery on Target is the industry’s preeminent event on novel drug targets and technologies. It highlights advances in current and emerging hot targets and technologies as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.
October 6-7, London, UK
The European Laboratory Research & Innovation Group’s Drug Discovery conference has become the largest meeting of life sciences industry professionals for the past 13 years in the UK. It highlights ground-breaking research and cutting-edge advances in the application of laboratory technology to understand disease biology and to identify novel chemical and biological candidate drugs.
November 2-4, Basel, Switzerland
The Festival of Biologics Europe looks at commercializing and pushing forward the entire developmental pipeline as well as focusing on the hottest new individual therapeutics. This conference will bring together more than 350 industry-leading speakers working on antibodies, immunotherapy, biosimilars, and clinical trials.